{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:22Z","timestamp":1787496502231,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2025079"],"award-info":[{"award-number":["2018R1A5A2025079"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1002792"],"award-info":[{"award-number":["2022R1A2C1002792"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1091055"],"award-info":[{"award-number":["2022R1A2C1091055"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal fibrosis is a consequence of chronic kidney disease, which is estimated to affect 10\u201314% of the global population. The molecular mechanisms in the pathogenesis of renal fibrosis are still unclear, and there is a lack of effective therapies. Here we identified decreased levels of p300\/CBP-associated factor (PCAF) in kidney tissues with fibrosis and demonstrated that PCAF-specific knockout in proximal tubular cells accelerates renal fibrosis in both unilateral ureteral obstruction surgery and folic acid-induced models. Conversely, overexpressing PCAF in the kidney using adenovirus mitigated unilateral ureteral obstruction-induced renal fibrosis. Importantly, PCAF inhibits the epithelial-to-mesenchymal transition of proximal tubular cells by transcriptionally activating adherens junction genes. Moreover, we observed that TGF-\u03b2 signaling induces lysosomal degradation of PCAF, suggesting that PCAF reduction is affected in the fibrotic milieu. These findings confirm that PCAF is a negative regulator of renal fibrosis and suggest that it could serve as a novel therapeutic target for patients with chronic kidney disease.<\/jats:p>","DOI":"10.1038\/s12276-025-01533-x","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:02:14Z","timestamp":1756684934000},"page":"2010-2021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Loss of PCAF in proximal tubular cells exacerbates renal fibrosis by promoting partial epithelial-to-mesenchymal transition"],"prefix":"10.1038","volume":"57","author":[{"given":"Hyunsik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghee","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunseung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Shik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3743-9554","authenticated-orcid":false,"given":"Soo-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-3863","authenticated-orcid":false,"given":"Jung-Yoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2718-3372","authenticated-orcid":false,"given":"Ho-Geun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/ijms22010408","volume":"22","author":"S Panizo","year":"2021","unstructured":"Panizo, S. et al. Fibrosis in chronic kidney disease: pathogenesis and consequences. Int. J. Mol. Sci. 22, 408 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1533_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","volume":"1165","author":"JC Lv","year":"2019","unstructured":"Lv, J. C. & Zhang, L. X. Prevalence and disease burden of chronic kidney disease. Adv. Exp. Med. Biol. 1165, 3\u201315 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.diff.2016.05.008","volume":"92","author":"YB Sun","year":"2016","unstructured":"Sun, Y. B., Qu, X., Caruana, G. & Li, J. The origin of renal fibroblasts\/myofibroblasts and the signals that trigger fibrosis. Differentiation 92, 102\u2013107 (2016).","journal-title":"Differentiation"},{"key":"1533_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 (2015).","journal-title":"Nat. Med."},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2016.54","volume":"12","author":"M Edeling","year":"2016","unstructured":"Edeling, M., Ragi, G., Huang, S., Pavenstadt, H. & Susztak, K. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat. Rev. Nephrol. 12, 426\u2013439 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.08.013","volume":"175","author":"B Roediger","year":"2018","unstructured":"Roediger, B. et al. An atypical parvovirus drives chronic tubulointerstitial nephropathy and kidney fibrosis. Cell 175, 530\u2013543 (2018).","journal-title":"Cell"},{"key":"1533_CR7","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282\u20132287 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1533_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46934-y","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Identifying key genes related to the peritubular capillary rarefaction in renal interstitial fibrosis by bioinformatics. Sci. Rep. 13, 19611 (2023).","journal-title":"Sci. Rep."},{"key":"1533_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047\u20131053 (2013).","journal-title":"Nat. Med."},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct. Target. Ther. 8, 129 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000313944","volume":"169","author":"N Nakhoul","year":"2011","unstructured":"Nakhoul, N. & Batuman, V. Role of proximal tubules in the pathogenesis of kidney disease. Contrib. Nephrol. 169, 37\u201350 (2011).","journal-title":"Contrib. Nephrol."},{"key":"1533_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1256375","volume":"14","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury. Front. Endocrinol. (Lausanne) 14, 1256375 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"1533_CR13","doi-asserted-by":"publisher","first-page":"eaaz2597","DOI":"10.1126\/scisignal.aaz2597","volume":"13","author":"S Lovisa","year":"2020","unstructured":"Lovisa, S. et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci. Signal 13, eaaz2597 (2020).","journal-title":"Sci. Signal"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Lu, Q. & Chang, C. Epigenetics in health and disease. Adv. Exp. Med. Biol. 1253, 3\u201355 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1533_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105910","volume":"173","author":"T Xue","year":"2021","unstructured":"Xue, T. et al. Epigenetic regulation in fibrosis progress. Pharm. Res. 173, 105910 (2021).","journal-title":"Pharm. Res."},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"21087","DOI":"10.3390\/ijms141021087","volume":"14","author":"S Sarkar","year":"2013","unstructured":"Sarkar, S. et al. Cancer development, progression, and therapy: an epigenetic overview. Int. J. Mol. Sci. 14, 21087\u201321113 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"1533_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neo.2019.03.011","volume":"21","author":"T Liu","year":"2019","unstructured":"Liu, T. et al. Epigenetically down-regulated acetyltransferase PCAF increases the resistance of colorectal cancer to 5-fluorouracil. Neoplasia 21, 557\u2013570 (2019).","journal-title":"Neoplasia"},{"key":"1533_CR18","first-page":"2772","volume":"6","author":"HJ Fei","year":"2016","unstructured":"Fei, H. J. et al. PCAF acts as a gastric cancer suppressor through a novel PCAF\u2013p16\u2013CDK4 axis. Am. J. Cancer Res. 6, 2772\u20132786 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"1533_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4161\/15592294.2014.990780","volume":"10","author":"J Huang","year":"2015","unstructured":"Huang, J. et al. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics 10, 62\u201372 (2015).","journal-title":"Epigenetics"},{"key":"1533_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185820","volume":"12","author":"RCM de Jong","year":"2017","unstructured":"de Jong, R. C. M. et al. The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development. PLoS ONE 12, e0185820 (2017).","journal-title":"PLoS ONE"},{"key":"1533_CR21","doi-asserted-by":"publisher","first-page":"604821","DOI":"10.3389\/fcvm.2020.604821","volume":"7","author":"A de\u00ffJong","year":"2020","unstructured":"de\u00ffJong, A. et al. P300\/CBP associated factor (PCAF) deficiency enhances diet-induced atherosclerosis in ApoE3(*)Leiden mice via systemic inhibition of regulatory T cells. Front. Cardiovasc. Med 7, 604821 (2020).","journal-title":"Front. Cardiovasc. Med"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1111\/jcmm.13877","volume":"22","author":"T Wang","year":"2018","unstructured":"Wang, T., Yao, W., Shao, Y., Zheng, R. & Huang, F. PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer. J. Cell Mol. Med. 22, 5787\u20135800 (2018).","journal-title":"J. Cell Mol. Med"},{"key":"1533_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01687-7","volume":"22","author":"B Pan","year":"2024","unstructured":"Pan, B., Liu, C., Su, J. & Xia, C. Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF. Cell Commun. Signal 22, 306 (2024).","journal-title":"Cell Commun. Signal"},{"key":"1533_CR24","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1080\/21655979.2021.1935525","volume":"12","author":"L Li","year":"2021","unstructured":"Li, L., Zhang, J. & Cao, S. Lysine Acetyltransferase 2B predicts favorable prognosis and functions as anti-oncogene in cervical carcinoma. Bioengineered 12, 2563\u20132575 (2021).","journal-title":"Bioengineered"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.canlet.2016.02.053","volume":"375","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial\u2013mesenchymal transition by targeting Gli-1. Cancer Lett. 375, 190\u2013198 (2016).","journal-title":"Cancer Lett."},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2019.03.157","volume":"513","author":"L Qiu","year":"2019","unstructured":"Qiu, L., Xu, C., Chen, J., Li, Q. & Jiang, H. Downregulation of the transcriptional co-activator PCAF inhibits the proliferation and migration of vascular smooth muscle cells and attenuates NF-\u03baB-mediated inflammatory responses. Biochem. Biophys. Res. Commun. 513, 41\u201348 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1533_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-96","volume":"12","author":"X Zheng","year":"2013","unstructured":"Zheng, X. et al. Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Mol. Cancer 12, 96 (2013).","journal-title":"Mol. Cancer"},{"key":"1533_CR28","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1242\/jcs.099697","volume":"125","author":"RY Huang","year":"2012","unstructured":"Huang, R. Y., Guilford, P. & Thiery, J. P. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J. Cell Sci. 125, 4417\u20134422 (2012).","journal-title":"J. Cell Sci."},{"key":"1533_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4161\/cam.21326","volume":"6","author":"GF Le Bras","year":"2012","unstructured":"Le Bras, G. F., Taubenslag, K. J. & Andl, C. D. The regulation of cell\u2013cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh. Migr. 6, 365\u2013373 (2012).","journal-title":"Cell Adh. Migr."},{"key":"1533_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cells4040631","volume":"4","author":"I Loeffler","year":"2015","unstructured":"Loeffler, I. & Wolf, G. Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction? Cells 4, 631\u2013652 (2015).","journal-title":"Cells"},{"key":"1533_CR31","doi-asserted-by":"publisher","first-page":"569322","DOI":"10.3389\/fphys.2020.569322","volume":"11","author":"L Sheng","year":"2020","unstructured":"Sheng, L. & Zhuang, S. New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis. Front. Physiol. 11, 569322 (2020).","journal-title":"Front. Physiol."},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","volume":"27","author":"S Lovisa","year":"2016","unstructured":"Lovisa, S., Zeisberg, M. & Kalluri, R. Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis. Trends Endocrinol. Metab. 27, 681\u2013695 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"1533_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1172\/JCI121987","volume":"129","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. PTEN-induced partial epithelial\u2013mesenchymal transition drives diabetic kidney disease. J. Clin. Invest. 129, 1129\u20131151 (2019).","journal-title":"J. Clin. Invest."},{"key":"1533_CR34","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1021\/acs.chemrestox.2c00258","volume":"35","author":"R Kandel","year":"2022","unstructured":"Kandel, R. & Singh, K. P. Higher concentrations of folic acid cause oxidative stress, acute cytotoxicity, and long-term fibrogenic changes in kidney epithelial cells. Chem. Res. Toxicol. 35, 2168\u20132179 (2022).","journal-title":"Chem. Res. Toxicol."},{"key":"1533_CR35","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1093\/nar\/gkx075","volume":"45","author":"A Perearnau","year":"2017","unstructured":"Perearnau, A. et al. p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes. Nucleic Acids Res. 45, 5086\u20135099 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1533_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5483\/BMBRep.2022-0188","volume":"56","author":"H Kim","year":"2023","unstructured":"Kim, H. et al. Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis. BMB Rep. 56, 114\u2013119 (2023).","journal-title":"BMB Rep."},{"key":"1533_CR37","doi-asserted-by":"publisher","first-page":"110407","DOI":"10.1016\/j.cellsig.2022.110407","volume":"98","author":"Y Gong","year":"2022","unstructured":"Gong, Y., Dou, Y., Wang, L., Wang, X. & Zhao, Z. EP300 promotes renal tubular epithelial cell fibrosis by increasing HIF2\u03b1 expression in diabetic nephropathy. Cell Signal 98, 110407 (2022).","journal-title":"Cell Signal"},{"key":"1533_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04881-y","volume":"13","author":"J Li","year":"2022","unstructured":"Li, J. et al. GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK\/p38 signaling pathway. Cell Death Dis. 13, 421 (2022).","journal-title":"Cell Death Dis."},{"key":"1533_CR39","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","volume":"154","author":"C Dou","year":"2018","unstructured":"Dou, C. et al. P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts. Gastroenterology 154, 2209\u20132221 (2018).","journal-title":"Gastroenterology"},{"key":"1533_CR40","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s12276-023-01066-1","volume":"55","author":"SY Lee","year":"2023","unstructured":"Lee, S. Y. et al. The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis. Exp. Mol. Med. 55, 1795\u20131805 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1533_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2020.09.017","volume":"495","author":"JH Oh","year":"2020","unstructured":"Oh, J. H. et al. Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer. Cancer Lett. 495, 145\u2013155 (2020).","journal-title":"Cancer Lett."},{"key":"1533_CR42","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1080\/15548627.2019.1707488","volume":"16","author":"C Ouyang","year":"2020","unstructured":"Ouyang, C. et al. Autophagic degradation of KAT2A\/GCN5 promotes directional migration of vascular smooth muscle cells by reducing TUBA\/alpha-tubulin acetylation. Autophagy 16, 1753\u20131770 (2020).","journal-title":"Autophagy"},{"key":"1533_CR43","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1128\/MCB.00358-13","volume":"33","author":"A Dar","year":"2013","unstructured":"Dar, A., Shibata, E. & Dutta, A. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell Biol. 33, 3309\u20133320 (2013).","journal-title":"Mol. Cell Biol."},{"key":"1533_CR44","doi-asserted-by":"crossref","unstructured":"Gao, G. et al. TGF-\u03b21 facilitates TAp63\u03b1 protein lysosomal degradation to promote pancreatic cancer cell migration. Biology 10, 597 (2021).","DOI":"10.3390\/biology10070597"},{"key":"1533_CR45","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.1074\/jbc.M111.308460","volume":"287","author":"SI Kim","year":"2012","unstructured":"Kim, S. I. et al. Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-beta1. J. Biol. Chem. 287, 11677\u201311688 (2012).","journal-title":"J. Biol. Chem."},{"key":"1533_CR46","doi-asserted-by":"publisher","first-page":"C1361","DOI":"10.1152\/ajpcell.00370.2006","volume":"292","author":"R Mishra","year":"2007","unstructured":"Mishra, R., Zhu, L., Eckert, R. L. & Simonson, M. S. TGF-beta-regulated collagen type I accumulation: role of Src-based signals. Am. J. Physiol. Cell Physiol. 292, C1361\u2013C1369 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1533_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita, N. & Kramann, R. Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol. Metab. 35, 31\u201348 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"1533_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.matbio.2017.12.013","volume":"68-69","author":"H Francois","year":"2018","unstructured":"Francois, H. & Chatziantoniou, C. Renal fibrosis: recent translational aspects. Matrix Biol. 68-69, 318\u2013332 (2018).","journal-title":"Matrix Biol."},{"key":"1533_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1533_CR50","first-page":"61","volume":"8","author":"AJ Knights","year":"2012","unstructured":"Knights, A. J., Funnell, A. P., Crossley, M. & Pearson, R. C. Holding tight: cell junctions and cancer spread. Trends Cancer Res. 8, 61\u201369 (2012).","journal-title":"Trends Cancer Res."},{"key":"1533_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183503","volume":"1863","author":"D Kyuno","year":"2021","unstructured":"Kyuno, D. et al. Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim. Biophys. Acta Biomembr. 1863, 183503 (2021).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"1533_CR52","doi-asserted-by":"crossref","unstructured":"Hu, Q. et al. Cell adhesion molecules in fibrotic diseases. Biomedicines 11, 1995 (2023).","DOI":"10.3390\/biomedicines11071995"},{"key":"1533_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107144","volume":"202","author":"L Luo","year":"2024","unstructured":"Luo, L. et al. The role of epithelial cells in fibrosis: mechanisms and treatment. Pharm. Res. 202, 107144 (2024).","journal-title":"Pharm. Res."},{"key":"1533_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1157-x","volume":"9","author":"R Qi","year":"2018","unstructured":"Qi, R. & Yang, C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 9, 1126 (2018).","journal-title":"Cell Death Dis."},{"key":"1533_CR55","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.18632\/aging.102950","volume":"12","author":"P Liu","year":"2020","unstructured":"Liu, P. et al. m(6)A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145\/FAK pathway. Aging 12, 5280\u20135299 (2020).","journal-title":"Aging"},{"key":"1533_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3892\/ijmm.2013.1396","volume":"32","author":"K Zhang","year":"2013","unstructured":"Zhang, K. et al. TGF-beta1 induces the dissolution of tight junctions in human renal proximal tubular cells: role of the RhoA\/ROCK signaling pathway. Int J. Mol. Med. 32, 464\u2013468 (2013).","journal-title":"Int J. Mol. Med."},{"key":"1533_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.59","volume":"6","author":"S Zhu","year":"2015","unstructured":"Zhu, S. et al. IGFBP-rP1 suppresses epithelial\u2013mesenchymal transition and metastasis in colorectal cancer. Cell Death Dis. 6, e1695 (2015).","journal-title":"Cell Death Dis."},{"key":"1533_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2613.2011.00775.x","volume":"92","author":"M Fragiadaki","year":"2011","unstructured":"Fragiadaki, M. & Mason, R. M. Epithelial-mesenchymal transition in renal fibrosis\u2014evidence for and against. Int. J. Exp. Pathol. 92, 143\u2013150 (2011).","journal-title":"Int. J. Exp. Pathol."},{"key":"1533_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03322-y","volume":"12","author":"R Qi","year":"2021","unstructured":"Qi, R. et al. Snai1-induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2\/M arrest in the progression of renal fibrosis via NF-\u03baB-mediated inflammation. Cell Death Dis. 12, 44 (2021).","journal-title":"Cell Death Dis."},{"key":"1533_CR60","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.kint.2022.11.027","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney Int. 103, 544\u2013564 (2023).","journal-title":"Kidney Int."},{"key":"1533_CR61","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/ijms20071554","volume":"20","author":"S Chung","year":"2019","unstructured":"Chung, S. et al. Inhibition of p300\/CBP-associated factor attenuates renal tubulointerstitial fibrosis through modulation of NF-kB and Nrf2. Int J. Mol. Sci. 20, 1544 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"1533_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/jm800657z","volume":"52","author":"M Arif","year":"2009","unstructured":"Arif, M. et al. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J. Med Chem. 52, 267\u2013277 (2009).","journal-title":"J. Med Chem."},{"key":"1533_CR63","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/acschembio.0c00719","volume":"15","author":"SI Son","year":"2020","unstructured":"Son, S. I. et al. Garcinol Is an HDAC11 Inhibitor. ACS Chem. Biol. 15, 2866\u20132871 (2020).","journal-title":"ACS Chem. Biol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01533-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:43:30Z","timestamp":1759981410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01533-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01533-x","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}